Paragraph 1 InterpretationE1

In this Schedule—

• F2...

• “pharmaceutical product” means any veterinary medicinal product other than an immunological product F3or a biological veterinary medicinal product that is not immunological;

• “simultaneous application” is an application in which, at the time an authorisation for a product is applied for, one or more additional applications are submitted for products that are identical to the first product except that—

  1. (a)

     in the case of an immunological product, they have a lesser number of antigens than the first product, but only contain antigens contained in the first product; and

  2. (b)

     in the case of a pharmaceutical product, they have different strengths of the active substance,

  F4...

For the purposes of this Schedule “manufacturing authorisation” means the following activities—